1. Home
  2. CHR vs MBIO Comparison

CHR vs MBIO Comparison

Compare CHR & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

N/A

Current Price

$1.36

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.41

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHR
MBIO
Founded
2016
2015
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.1M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
CHR
MBIO
Price
$1.36
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 85.4K
36.0K
Earning Date
07-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
★ 0.06
N/A
Revenue
N/A
N/A
Revenue This Year
$105.44
N/A
Revenue Next Year
$30.02
$405.45
P/E Ratio
$22.87
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.35
52 Week High
$2.95
$1.45

Technical Indicators

Market Signals
Indicator
CHR
MBIO
Relative Strength Index (RSI) 44.14 47.56
Support Level $0.73 N/A
Resistance Level $1.69 $0.56
Average True Range (ATR) 0.13 0.03
MACD -0.00 0.01
Stochastic Oscillator 33.78 76.14

Price Performance

Historical Comparison
CHR
MBIO

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: